Literature DB >> 26251091

Neprilysin in Heart Failure: From Oblivion to Center Stage.

Antoni Bayés-Genís1.   

Abstract

Entities:  

Keywords:  BNP; heart failure; neprilysin; physiology

Mesh：

Substances：

Year:  2015        PMID： 26251091     DOI： 10.1016/j.jchf.2015.03.010

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN： 2213-1779            Impact factor:   12.035


× No keyword cloud information.
  9 in total

Review 1.  Neprilysin and Natriuretic Peptide Regulation in Heart Failure.

Authors:  Antoni Bayes-Genis; Nuria Morant-Talamante; Josep Lupón
Journal:  Curr Heart Fail Rep       Date:  2016-08

2.  ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure.

Authors:  Nadia Aspromonte; Michele Massimo Gulizia; Aldo Clerico; Giuseppe Di Tano; Michele Emdin; Mauro Feola; Massimo Iacoviello; Roberto Latini; Andrea Mortara; Roberto Valle; Gianfranco Misuraca; Claudio Passino; Serge Masson; Alberto Aimo; Marcello Ciaccio; Marco Migliardi
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

3.  Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach.

Authors:  Oriol Iborra-Egea; Carolina Gálvez-Montón; Santiago Roura; Isaac Perea-Gil; Cristina Prat-Vidal; Carolina Soler-Botija; Antoni Bayes-Genis
Journal:  NPJ Syst Biol Appl       Date:  2017-04-18

Review 4.  New pharmacological and technological management strategies in heart failure.

Authors:  Sunit-Preet Chaudhry; Garrick C Stewart
Journal:  Vasc Health Risk Manag       Date:  2017-03-21

Review 5.  Cardiovascular Pleiotropic Effects of Natriuretic Peptides.

Authors:  Maurizio Forte; Michele Madonna; Sonia Schiavon; Valentina Valenti; Francesco Versaci; Giuseppe Biondi Zoccai; Giacomo Frati; Sebastiano Sciarretta
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

Review 6.  Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure.

Authors:  Diana-Carina Iovanovici; Simona Gabriela Bungau; Cosmin Mihai Vesa; Madalina Moisi; Elena Emilia Babes; Delia Mirela Tit; Tunde Horvath; Tapan Behl; Marius Rus
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

Review 7.  Angiotensin receptor/neprilysin inhibitor-a breakthrough in chronic heart failure therapy: summary of subanalysis on PARADIGM-HF trial findings.

Authors:  Marcin Książczyk; Małgorzata Lelonek
Journal:  Heart Fail Rev       Date:  2020-05       Impact factor: 4.214

8.  Soluble neprilysin and long-term clinical outcomes in patients with coronary artery disease undergoing percutaneous coronary intervention: a retrospective cohort study.

Authors:  Ik Jun Choi; Sungmin Lim; Youngdeok Hwang; Dongjae Lee; Won Jik Lee; Kwan Yong Lee; Mi-Jeong Kim; Doo Soo Jeon
Journal:  BMC Cardiovasc Disord       Date:  2020-08-06       Impact factor: 2.298

Review 9.  Where are we in 2021 with heart failure with reduced ejection fraction?-current outlook and expectations from new promising clinical trials.

Authors:  Agnieszka Dębska-Kozłowska; Marcin Książczyk; Małgorzata Lelonek
Journal:  Heart Fail Rev       Date:  2021-05-29       Impact factor: 4.214
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.